https://www.selleckchem.com/products/osmi-1.html
[This corrects the article on p. 8833 in vol. 13, PMID 34539998.]. This study aimed to investigate the efficacy of vitamin K1 in patients undergoing HSCT and find a feasible and safe option for HSCT patients to prevent bleeding. A retrospective analysis was performed on 96 HSCT patients admitted to the Department of Hematology of Wuhan Union Hospital from January 2018 to July 2019. Patients were divided into two groups (the vitamin K1 group and the control group) based on the administration of vitamin K1. All patients were reexamined for
Aimer
Commentaire
Partagez
